10:19 AM EST - Fennec Pharmaceuticals Inc. : Announced today a publication in the June 21 issue of the New England Journal of Medicine for STS in the prevention of cisplatin induced ototoxicity in pediatric patients. Fennec Pharmaceuticals Inc.
shares T.FRX are trading down $0.52 at $14.26.
